FA · First Advantage Corporation · Stock research

Refresh of coverage first published 2026-07-15, last updated 2026-08-09. The sponsor-supply risk flagged in that note as an unobserved possibility became an observed event four sessions later.

Current Thesis

The Aug 6 earnings breakout was interrupted by its own register. On 2026-08-11 that deal priced at 12,500,000 shares for $22.20, an aggregate $277.5M, with J.P. Morgan Securities as underwriter and closing on 2026-08-12. The company sold nothing and received no proceeds. Price has since worked lower to a 2026-08-21 close of $20.90, 13.3% under the $24.12 52-week high and below the $22.20 at which the sponsor found institutional demand.

The fundamental leg is unchanged and still fresh: Q2 revenue of $448.8M, +14.9% YoY against a $415.0M consensus, adjusted diluted EPS $0.35 against $0.28, and the first FY guidance raise of the cycle to $1.67–1.71B. What changed is the marginal seller. The narrative an investor is buying here is a deleveraging, cash-generative screening operator whose accelerating growth is being priced against a known, registered supply pipeline rather than against its own numbers. Those are two different clocks, and only one of them is company-controlled.

Bullish and bearish views on First Advantage Corporation

The model's bull view on First Advantage Corporation (FA), in brief: Q2 2026 (2026-08-06): revenue $448.8M, +14.9% YoY, versus $415.0M consensus — an acceleration from the +8.6% printed at Q1 on 2026-05-08, on a like-for-like post-Sterling base (the $2.2B Sterling acquisition closed 2024-10-31, so the year-ago quarter already contained it). The bear view: The deal cleared at $22.20 on 2026-08-11 and price has it. Both cases follow in full.

Bull Case

• Q2 2026 (2026-08-06): revenue $448.8M, +14.9% YoY, versus $415.0M consensus — an acceleration from the +8.6% printed at Q1 on 2026-05-08, on a like-for-like post-Sterling base (the $2.2B Sterling acquisition closed 2024-10-31, so the year-ago quarter already contained it).
• Base revenue — existing customers' screening volumes — grew 6.7% in Q2 while US payroll growth was cooling; upsell, cross-sell and new-logo revenue grew 12.5%, with 20 enterprise bookings closed in the quarter.
• Adjusted EBITDA $128.5M at a 28.6% margin, up 13% YoY; GAAP net income $16.9M, $0.10 diluted.
• FY2026 guidance raised on all three lines on 2026-08-06: revenue to $1.67–1.71B from $1.625–1.700B, adjusted EBITDA to $472–486M from $460–485M, adjusted diluted EPS to $1.23–1.29 from $1.15–1.25 against a $1.22 consensus.
• Cash is going to the balance sheet: voluntary debt prepayments of $25M on 2026-05-06 and $45M on 2026-08-04, against $2,033.8M long-term debt and $237.9M cash at 2026-06-30. Buybacks of $18.7M in Q2 and $38.2M year-to-date through 2026-07-31, roughly 1.9% of shares outstanding.
• The published target frame sits above the tape after the drawdown. Per stockanalysis.com on 2026-08-21, ten analysts average $26.25 with a Buy consensus: BMO Buy/$28, J.P. Morgan Buy/$28, Stifel Buy/$27, Citigroup Hold/$22 (raised on 2026-08-17), against a $20.90 close. Needham upgraded to Buy on 2026-08-06.
• A secondary is a change of holder, not of share count. No new shares were issued and no dilution occurred; the float widened while the company was simultaneously retiring stock.

Bear Case

• The deal cleared at $22.20 on 2026-08-11 and price has it. A stock trading under the level at which a book was built two weeks earlier says the institutional demand curve was filled at $22.20 and thinned above it.
• Whatever fraction remains after the 12.5M sold and the up-to-4,200,000 distributed to limited partners is pre-cleared to come to market. That is a standing, dated overhang rather than a rumour.
• The selling stockholder agreed to only a 30-day lock-up with the underwriter from the 2026-08-12 close — expiring around 2026-09-11 — and the shares distributed to limited partners at closing were expressly not subject to it. Distributed shares reach holders with no restriction.
• Citigroup's 2026-08-17 note, the most recent published action in the set, carries a $22 target at Hold — below the deal price and only modestly above spot.
• The FY raise was small next to the beat: revenue printed $448.8M against $415.0M consensus, yet the FY revenue ceiling moved only from $1.700B to $1.710B. Implied second-half revenue was barely marked up.
• Base revenue growth of 6.7% is the line levered to hiring, and hiring is decelerating: US payrolls +57k in June against +129k in May. Screening volumes follow that series with a lag, and nothing company-specific is scheduled to update it before the Q3 report.
• $2,033.8M of long-term debt against $237.9M cash means a volume air-pocket slows the deleveraging arithmetic that underwrites the equity re-rate.

Setup & Price Structure

The 2026-08-21 close of $20.90 sits inside the pre-print July range of $19.91–$22.49, which is where the stock traded before the Q2 beat. The Aug 6 gap has been retraced. RSI(14) at 52.2 is neutral — the decline has been orderly supply absorption rather than a momentum flush — and the three-month price change is still +35.5%, so the first leg of the move remains intact even after 13.3% off the high.

Positioning observables, stated without a verdict: the anchor holder sold 12.5M shares into strength four sessions after a 52-week high and registered up to 87.45M for resale on the same day; up to 4.2M shares went to limited partners unrestricted at closing; the company was repurchasing stock ($38.2M year-to-date through 2026-07-31) while the sponsor was distributing it; the underwriter lock-up runs only ~30 days from 2026-08-12; and there is no company-reported event between now and an estimated early-November Q3 print to re-anchor the tape. Sell-side dispersion is wide — $22 to $28 among the five most recently dated targets — which is a fact about disagreement, not a forecast.

The narrative is maturing. The narrative is well known and still working on the numbers — the guidance raise dated 2026-08-06 and the $26.25 average target dated 2026-08-21 are both current — but the incremental bid is now being met by pre-registered supply rather than by fresh attention, and the highest-frequency input (payrolls) is decelerating. It is not dead: the fundamental step-up has not been contradicted by any disclosure. It moves toward saturated if the $22.20 deal price is not reclaimed and the lock-up expiry passes without a bid.

Catalyst Calendar (next 30 days)

• 2026-09-04 — US August employment report (BLS, first-Friday release). The base-revenue line tracks hiring volume; June's +57k against May's +129k is the trend the 6.7% organic growth has to keep surviving.
• ~2026-09-11 (est.) — expiry of the selling stockholder's 30-day underwriter lock-up dated from the 2026-08-12 closing. Removes the last contractual restraint on the remainder of the 87.45M registered shares.
• ~2026-11-05 (est.) — Q3 2026 results. Outside the 30-day window; noted because it is the next company-controlled datapoint, and nothing company-specific is scheduled before it.

What Would Change Our Mind

The structure that defined the second leg has already been given back: the Aug 6 breakout shelf and the $22.20 clearing price are both above the tape. The remaining question is whether the pre-print July base holds. A weekly close below $19.91 puts price under the entire range that preceded the Q2 beat and says the raise bought nothing durable — that is the gradeable break.

Secondary conditions that would independently downgrade the read: the ~2026-09-11 lock-up expiry passing with a further registered sale announced from the 87.45M shelf; base revenue growth printing under 6.7% at the Q3 report, or the FY revenue range trimmed from $1.67–1.71B; voluntary prepayments pausing after the 2026-08-04 $45M. On the other side, a weekly close back above $22.49 would reclaim the July range top and the deal price together, which would say the supply was absorbed.

Correlation Notes

• The dominant exogenous input is US non-farm payrolls, not AI capex or semiconductor cycles. Monthly BLS releases move the volume assumption behind the base-revenue line more than any company release between quarters.
• Trades with staffing and human-capital services (Robert Half, Heidrick & Struggles, Korn Ferry) on hiring-cycle prints, but the screening model is transactional per-check rather than placement-fee, so revenue decays more slowly than placement revenue in a hiring downturn and re-accelerates later.
• $2,033.8M of long-term debt makes the equity sensitive to credit conditions and floating-rate expectations independent of operating results; deleveraging headlines and rate moves both re-price the same claim.
• Belongs to the cohort of 2020–21 sponsor-backed IPOs where a registered resale shelf, not fundamentals, is the near-term price-setter. Correlation there is to the mechanics of the supply calendar rather than to the sector.